Braskem SA Class A (BAK) Stock Forecast & Price Target
Braskem SA Class A · NYSE
$2.37-0.07 (-3.07%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Braskem SA Class A, 0 rate it Buy or better, 2 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $3.80 to $5.00, so the covering firms are broadly aligned. The average target of $4.40 sits 86% above the current $2.37. Sentiment has cooled somewhat, with Sell ratings rising from 0 to 1 over recent months. On the fundamentals, the Street sees revenue growth near 13% this year and 4% next, consensus EPS building from about $-2.76 next quarter toward $-1.83 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy00%
Hold267%
Sell133%
Strong Sell00%
Based on 3 analysts giving stock ratings to Braskem SA Class A.
As of Jul, 0 of 3 firms rate BAK a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
BAK EPS & revenue forecast
EPS · NEXT QUARTER
$-2.76
Range $-2.76 – $-2.76 · 1 analysts · -63030% YoY
Next period, 1 analysts expect Braskem SA Class A to earn $-2.76 a share (range $-2.76 – $-2.76), versus $0.00 a year earlier. Full-year consensus is $0.86, growing to $-1.83 the year after.
REVENUE · NEXT QUARTER
$22.5B
Range $21.7B – $23.4B · 1 analysts · +30% YoY
Revenue is expected to reach $22.5B (range $21.7B – $23.4B), +30.0% year-over-year. Full-year consensus is $77.8B, rising to $80.7B next year.
Top analysts covering Braskem SA Class A
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BAK.
#1
TV
Tasso Vasconcellos
UBS
Hold
$3.80+60.7% to target
Coverage
—
+ Follow
#2
GB
Gabriel Barra
Citigroup
Sell
No targeton BAK
Coverage
—
+ Follow
#3
RR
Ricardo Rezende
JP Morgan
Hold
$5.00+111.4% to target
Coverage
—
+ Follow
#4
LC
Luiz Carvalho
UBS
Buy
$10.00+322.8% to target
Coverage
—
+ Follow
BAK stock forecast FAQ
What is BAK's average 12-month price target?+
The 2 analysts with a live target average $4.40 for Braskem SA Class A over the next 12 months, ranging from a $5.00 high to a $3.80 low.
Is BAK stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 0 are Buy or Strong Buy, 2 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for BAK?+
The Street-high target is $5.00 (JP Morgan), and the Street-low is $3.80 (UBS). The average of all 2 active targets is $4.40.
How many Wall Street analysts cover BAK?+
3 analysts have an active rating on Braskem SA Class A, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering BAK?+
Among analysts who currently cover BAK, Tasso Vasconcellos of UBS has the strongest overall Quantellect track record. Their current call is Hold with a $3.80 target.
What is Braskem SA Class A's projected EPS for next quarter?+
The consensus estimate is $-2.76 per share (range $-2.76 – $-2.76) across 1 analysts. Full-year EPS is projected at $0.86, rising to $-1.83 the following year.
How much revenue is Braskem SA Class A expected to report next quarter?+
Consensus revenue is $22.5B (range $21.7B – $23.4B). Full-year revenue is projected at $77.8B, growing to $80.7B next year.
Have analysts been upgrading or downgrading BAK lately?+
As of Jul, 0 of 3 firms rate BAK a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BAK calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
JP Morgan
